Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Key Laboratory of Gut Microbiota Translational Medicine Research, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Front Endocrinol (Lausanne). 2023 Jan 10;13:1028275. doi: 10.3389/fendo.2022.1028275. eCollection 2022.
Currently, complete tumor resection is considered the most effective treatment for rectal neuroendocrine tumors (NETs). Endoscopic submucosal dissection (ESD) and transanal endoscopic microsurgery (TEM) are recommended for rectalNETs ≤2 cm, but it is not clear which method is better. Thus, we evaluated the efficacy of ESD and TEM in the treatment of rectal neuroendocrine tumors (NETs) ≤ 2 cm.
We conducted a single-centre retrospective cohort study between 2010 and 2021 of rectal NETs ≤ 2 cm in 114 patients with long-term follow-up data who were divided into ESD (n=55) and TEM groups (n=59). Our study assessed differences between groups in the complete resection rate of lesions, recurrence rate, surgical complications, procedure time, and length of hospital stay.
The co-primary outcomes were the complete resection rate of lesions and the recurrence rate. Compared to that in the ESD group, the complete resection rate was significantly higher in the TEM group (91.5% vs. 70.9%, =0.005). The median follow-up time was 22 months in our study, and the follow-up outcomes suggested that the rates of recurrence were 1.8% (1/55) and 6.8% (4/59) in the ESD and TEM groups, respectively, with no significant difference between the two groups. The secondary outcomes of the evaluation were surgical complications, procedural time, and length of hospital stay. The rate of complications (gastrointestinal bleeding and perforation) was low in both the ESD (7.3%, 4/55) and TEM (5.1%, 3/59) groups. No difference in hospitalization duration was observed between the two groups in our study. However, the procedure time was significantly shorter in the ESD group than in the TEM group (27.5 min vs. 56 min, <0.001).
Although the rate of complete resection in the TEM group was higher than that in the ESD group, there was no difference in recurrence rates between the two modalities during long-term follow-up. Depending on the qualities of the available hospital resources in the area, one of the two approaches can be adopted.
目前,完整的肿瘤切除被认为是治疗直肠神经内分泌肿瘤(NET)最有效的方法。对于直肠 NETs≤2cm,建议采用内镜黏膜下剥离术(ESD)和经肛门内镜微创手术(TEM),但哪种方法更好尚不清楚。因此,我们评估了 ESD 和 TEM 在治疗直肠神经内分泌肿瘤(NET)≤2cm 中的疗效。
我们进行了一项单中心回顾性队列研究,纳入了 114 例长期随访资料的直肠 NETs≤2cm 患者,分为 ESD 组(n=55)和 TEM 组(n=59)。我们的研究评估了两组在病变完全切除率、复发率、手术并发症、手术时间和住院时间方面的差异。
主要研究结果为病变完全切除率和复发率。与 ESD 组相比,TEM 组的完全切除率明显更高(91.5% vs. 70.9%,=0.005)。我们的研究中位随访时间为 22 个月,随访结果显示 ESD 组和 TEM 组的复发率分别为 1.8%(1/55)和 6.8%(4/59),两组之间无显著差异。次要评估结果为手术并发症、手术时间和住院时间。ESD(7.3%,4/55)和 TEM(5.1%,3/59)两组的并发症(胃肠道出血和穿孔)发生率均较低。两组的住院时间无显著差异。然而,ESD 组的手术时间明显短于 TEM 组(27.5min vs. 56min,<0.001)。
虽然 TEM 组的完全切除率较高,但在长期随访中两种方法的复发率无差异。根据当地医院资源的质量,可以采用两种方法之一。